| Literature DB >> 26203430 |
Sivarathy Amarasinghe1, Sandrasegarampillai Balakumar1, Vasanthy Arasaratnam1.
Abstract
BACKGROUND: The aim was to determine the prevalence and factors associated with Metabolic Syndrome (MS) among adults aged over 18 years in Jaffna district, Sri Lanka.Entities:
Keywords: Central obesity; Fasting plasma glucose; High density lipoprotein; Hypertriacylglycerolaemia; Metabolic syndrome
Year: 2015 PMID: 26203430 PMCID: PMC4511035 DOI: 10.1186/s40200-015-0190-x
Source DB: PubMed Journal: J Diabetes Metab Disord ISSN: 2251-6581
Components of metabolic syndrome (MS) in the study population stratified by gender
| Components of MS | Reference values | Male | Female | Total |
| |||
|---|---|---|---|---|---|---|---|---|
| (No) | (%) | (No) | (%) | (No) | (%) | |||
| Central obesity | WC ≥ 102 cm in males, ≥88 cm in females | 28 | 12.5 | 55 | 19.2 | 83 | 16.2 | 0.000a |
| Raised glucose level | FPG ≥100 mg/dL or previously disdiagnosed type 2 diabetes | 60 | 26.8 | 62 | 21.6 | 122 | 23.9 | 0.176 |
| Raised triacylglycerol level | TAG > 150 mg/dL or specific treatment of lipid abnormality | 63 | 28.1 | 65 | 22.6 | 128 | 25.0 | 0.181 |
| Low high density lipoprotein level | HDL < 40 mg/dL in males, <50 mg/dL in females | 181 | 80.8 | 224 | 78 | 405 | 79.3 | 0.51 |
| Raised blood pressure | Systolic BP ≥ 130 or Diastolic BP ≥ 85 mmHg or previously diagnosed hypertension | 101 | 45.1 | 86 | 30.0 | 187 | 36.6 | 0.001a |
Modified NCEP ATP III (2004) was used to identify the components of metabolic syndrome
asignificance difference in components of metabolic syndrome between male and female participants
Mean values of anthropometric indicators and selected biochemical parameters of participants with and without metabolic syndrome
| Variables | Mean | ||
|---|---|---|---|
| Participants with MS | Participants without MS |
| |
| Weight (kg) | 61.7 ± 13.2 | 55.0 ± 11.4 | 0.000a |
| BMI (kg/m2) | 24.9 ± 4.7 | 22.5 ± 4.0 | 0.000a |
| WC (cm) | 89.6 ± 12.3 | 79.4 ± 11.9 | 0.000a |
| HC (cm) | 95.2 ± 14.3 | 88.9 ± 14.5 | 0.000a |
| WHR | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.000a |
| SBP (mm Hg) | 129 ± 18 | 115 ± 16 | 0.000a |
| DBP (mm Hg) | 83 ± 10 | 75 ± 11 | 0.000a |
| FPG (mg/dL) | 126.2 ± 53.2 | 83.8 ± 24 | 0.000a |
| HDL (mg/dL) | 32.8 ± 8.8 | 35.0 ± 9.9 | 0.025a |
| TAGs (mg/dL) | 164 ± 38.3 | 92.6 ± 34.1 | 0.000a |
Modified NCEP ATP III definition of the metabolic syndrome (2004) was used to identify the participants with metabolic syndrome
asignificance difference between participants with metabolic syndrome and participants without metabolic syndrome
Prevalence of metabolic syndrome (MS) among the selected participants based on demographic factors
| Male | Female | Total |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Participants | MS | Subject | MS | Participants | MS | ||||||||
| (No) | (%) | (No) | (%) | (No) | (%) | (No) | (%) | (No) | (%) | (No) | (%) | ||
| Gender | 224 | 43.8 | 60 | 26.8 | 287 | 56.2 | 63 | 21.9 | 511 | 123 | 24.1 | 0.212 | |
| Sector | 0.019a | ||||||||||||
| Rural | 166 | 77.1 | 41 | 24.7 | 228 | 79.4 | 44 | 19.3 | 394 | 77.1 | 85 | 21.6 | |
| Urban | 58 | 22.9 | 19 | 32.8 | 59 | 20.6 | 19 | 32.2 | 117 | 22.9 | 38 | 32.5 | |
| Age (Years) | 0.000a | ||||||||||||
| 18–34 | 48 | 26 | 5 | 104 | 85 | 29.6 | 7 | 8.2 | 133 | 26 | 12 | 9 | |
| 35–49 | 69 | 31.7 | 13 | 14.8 | 93 | 32.4 | 11 | 11.8 | 162 | 31.7 | 24 | 14.8 | |
| 50–64 | 75 | 31.5 | 28 | 36.6 | 86 | 30 | 31 | 36 | 161 | 31.5 | 59 | 36.6 | |
| >65 | 32 | 10.8 | 14 | 50.9 | 23 | 8.0 | 14 | 60.9 | 55 | 10.8 | 28 | 50.9 | |
Modified NCEP ATP III definition of the metabolic syndrome (2004) was used to identify the participants with metabolic syndrome
asignificance difference in components of metabolic syndrome between male and female participants